Panacea Hopes Bionpharma Deal Can Aid Recovery

 
• By Penelope MacRae

India’s Panacea Biotec is hoping an alliance with New Jersey-based pharmaceutical startup Bionpharma Inc to make seven complex generic drugs for the US with a potential market of over $800m will help its financial recovery.

Pharma pills
PANACEA HOPES THE BIONPHARMA DEAL WILL IMPROVE ITS FINANCIALS

More from Business

More from Scrip